LWAC
GILD icon

Laurel Wealth Advisors (California)’s Gilead Sciences GILD Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$943K Sell
10,983
-30
-0.3% -$2.38K 0.09% 224
2022
Q3 		$680K Sell
11,013
-50
-0.5% -$3.15K 0.07% 288
2022
Q2 		$684K Sell
11,063
-1,078
-9% -$66.7K 0.07% 283
2022
Q1 		$722K Buy
12,141
+362
+3% +$23.1K 0.06% 319
2021
Q4 		$855K Buy
11,779
+4,511
+62% +$311K 0.07% 305
2021
Q3 		$508K Sell
7,268
-1,772
-20% -$124K 0.09% 226
2021
Q2 		$623K Buy
9,040
+75
+0.8% +$5.01K 0.08% 237
2021
Q1 		$579K Sell
8,965
-1,739
-16% -$112K 0.09% 222
2020
Q4 		$623K Sell
10,704
-238
-2% -$14.4K 0.09% 211
2020
Q3 		$691K Buy
10,942
+2,335
+27% +$162K 0.11% 190
2020
Q2 		$662K Sell
8,607
-2,031
-19% -$156K 0.12% 182
2020
Q1 		$795K Buy
10,638
+1,842
+21% +$127K 0.18% 139
2019
Q4 		$572K Sell
8,796
-4,105
-32% -$267K 0.1% 224
2019
Q3 		$818K Buy
12,901
+1,622
+14% +$106K 0.14% 173
2019
Q2 		$762K Buy
11,279
+518
+5% +$34.1K 0.17% 145
2019
Q1 		$700K Buy
10,761
+1,307
+14% +$86.9K 0.17% 142
2018
Q4 		$591K Sell
9,454
-2,516
-21% -$176K 0.17% 139
2018
Q3 		$924K Sell
11,970
-1,146
-9% -$86.5K 0.23% 108
2018
Q2 		$929K Buy
13,116
+2,828
+27% +$200K 0.25% 103
2018
Q1 		$775K Buy
10,288
+562
+6% +$44.7K 0.24% 107
2017
Q4 		$696K Buy
9,726
+1,780
+22% +$135K 0.2% 119
2017
Q3 		$643K Buy
7,946
+564
+8% +$43.1K 0.22% 112
2017
Q2 		$522K Buy
7,382
+531
+8% +$35.3K 0.19% 133
2017
Q1 		$465K Sell
6,851
-341
-5% -$24K 0.18% 145
2016
Q4 		$515K Sell
7,192
-524
-7% -$38.9K 0.23% 113
2016
Q3 		$610K Sell
7,716
-839
-10% -$68.2K 0.29% 95
2016
Q2 		$714K Buy
8,555
+2,828
+49% +$251K 0.34% 80
2016
Q1 		$526K Sell
5,727
-1,660
-22% -$150K 0.26% 96
2015
Q4 		$747K Buy
+7,387
New +$769K 0.39% 74

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Laurel Wealth Advisors (California)'s GILD Position: Q4 2022 in Review

Laurel Wealth Advisors (California) reduced its Gilead Sciences (GILD) stake by 0.27% in Q4 2022, selling an estimated $2.38K and leaving 10,983 shares worth $943K. The position accounts for 0.09% of the portfolio, ranked #224.

Laurel Wealth Advisors (California) first reported a position in GILD in Q4 2015 and has held it in 29 quarters since. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Laurel Wealth Advisors (California) held 10,983 shares of Gilead Sciences worth $943K as of Q4 2022.
  • Laurel Wealth Advisors (California) sold 30 Gilead Sciences shares in Q4 2022, an estimated $2.38K.
  • Gilead Sciences made up 0.09% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #224 holding.
  • Laurel Wealth Advisors (California) first reported a position in Gilead Sciences in Q4 2015 and has held it in 29 quarters since.
  • 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.